资讯
20 小时on MSN
The AI drug breakthrough is taking a long time to arrive for reasons that may have little ...
It wasn’t always this way. Leveraging AI in drug development is not only thanks to growing access to semiconductor chips, but ...
You can create a release to package software, along with release notes and links to binary files, for other people to use. Learn more about releases in our docs.
A distributed, recursive Deep Research Agent powered by Resonate and OpenAI. This example demonstrates how complex, distributed agentic applications can be implemented with simple, composable code.
Recursion Pharmaceuticals, Inc. ( NASDAQ: RXRX) Morgan Stanley 23rd Annual Global Healthcare Conference September 8, 2025 4:05 PM EDT ...
Autonomous AI agents are more than just extensions of vendor tools. They’re credentialed actors who connect and execute, and ...
McKinsey’s 2025 Tech Trends report identifies 13 enterprise AI focus areas, highlighting agentic AI, semiconductors, quantum, ...
Recursion Pharmaceuticals, Inc. (NASDAQ:RXRX) is one of Wednesday’s worst performers. Recursion Pharmaceuticals dropped for a third straight day on Wednesday, slashing 6.29 percent to close at $4.77 ...
Eliezer Yudkowsky and Nate Soares argue AI could legitimately take over the world in their new book, If Anyone Builds it, ...
This price reflects trading activity during the overnight session on the Blue Ocean ATS, available 8 p.m. to 4 a.m. ET, Sunday through Thursday, when regular markets are closed.
一些您可能无法访问的结果已被隐去。
显示无法访问的结果